RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Update Il y a 4 ans
Reference: NCT01490086

Woman and Man

Extract

The objective of this study is to evaluate the efficacy and safety of RP5063 relative to placebo for the treatment of schizophrenia or schizoaffective disorder.


Inclusion criteria

  • Acute Schizophrenia ,Schizoaffective Disorder


Links